Insulin pen needles and syringes are the commonly used devices by diabetics for injecting insulin. Although injecting with the use of the syringe is still the most predominant method, more people are seeing the benefits of using insulin pen device and diabetic pen needles. Insulin pens came out in the mid-1980s when the only method known is through syringe injection.
North America Pen Needles Market size is projected to reach approximately $0.81 billion by the end of 2024 with a CAGR of close to 10.60% from $0.55 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include rising diabetes prevalence, a comparative advantage over syringes and vials, technological advancements, increasing awareness of the general public, government support in certain countries. However, reusability of pen needles, complications associated with needle use, availability of alternative dosage forms, poor reimbursement policies in underdeveloped and developing countries are thereby hampering the market growth.
North America Pen Needles Market is categorised into therapy which comprises growth hormone, Insulin, and GLP-1. Among them, insulin therapy segment is expected to hold
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.